Search results for: England

Adaptation to Health States: Sick Yet Better Off?

21 June 2017

…However, controversy remains on the methodological underpinning of how health outcome measurements are obtained. For instance, health technology assessment in England by the National Institute of Health and Care Excellence…

OHE Lunchtime Seminar: NHS Agency Staffing and the Impact of Recent Interventions

6 September 2017

…and the impact of recent interventions. Temporary agency staffing has been a major area of focus for the NHS in England over the last five years. In the context of…

OHE at ISPOR’s 20th Annual European Congress: Presentations

…last 20 years. There are important differences between the 5L value set for England and the UK 3L value set, but, to some extent, these are attributable to the ‘unusual’…

Comparing Preference-based Outcome Measures for Overactive Bladder: EQ-5D-5L vs OAB-5D

31 January 2018

…calculated using the recently published EQ-5D-5L value set for England, making this one of the first published analyses to be carried out using the new value set. In the 2,054…

Valuing Health at the End of Life: A Review of Stated Preference Studies in the Social Sciences Literature

9 April 2018

…in England, where since 2009 NICE has adopted a supplementary policy in its technology appraisal programme that effectively applies a premium for life-extending end of life treatments. Public preferences have…

Invitation to OHE’s Annual Lecture 2018: Is There an Economic Case for Investing in the NHS? Really?

11 July 2018

…is a good use of public finance. The UK government’s decision to increase NHS England’s budget by £20bn in real terms by 2023 is widely regarded as not enough by…

How Much Should Society Pay for a New Orphan Drug? A Contribution to this Debate is now Available in a New OHE Research Paper

18 July 2018

…(England) and SMC (Scotland) regarding novel drugs approvals in our sample to collect data on patient population sizes. Although in the algebraic formulation, the authors consider a number other factors,…

Two New Papers on EQ-5D-5L Valuation in Ireland

21 August 2018

…for the EQ-5D-5L. PharmacoEconomics. DOI Related research Devlin, N., Shah, K., Feng, Y., Mulhern, B. and van Hout, B., 2018. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Economics,…

Measuring UK Medicines Expenditure in the Context of the 2014-18 PPRS

29 August 2018

…for the English National Health Service (NHS) for the same period at 8.0%. However, NHS Digital reported much-reduced medicines expenditure growth for England of 3.5% for 2016/17, suggesting a complex…